Current:Home > InvestPig transplant research yields a surprise: Bacon safe for some people allergic to red meat -GrowthProspect
Pig transplant research yields a surprise: Bacon safe for some people allergic to red meat
View
Date:2025-04-23 09:40:37
BLACKSBURG, Va. (AP) — Some people who develop a weird and terrifying allergy to red meat after a bite from a lone star tick can still eat pork from a surprising source: Genetically modified pigs created for organ transplant research.
Don’t look for it in grocery stores. The company that bred these special pigs shares its small supply, for free, with allergy patients.
“We get hundreds and hundreds of orders,” said David Ayares, who heads Revivicor Inc., as he opened a freezer jammed with packages of ground pork patties, ham, ribs and pork chops.
The allergy is called alpha-gal syndrome, named for a sugar that’s present in the tissues of nearly all mammals - except for people and some of our primate cousins. It can cause a serious reaction hours after eating beef, pork or any other red meat, or certain mammalian products such as milk or gelatin.
David Ayares, president and chief scientific officer of Revivicor, holds a package of frozen meat during an interview at the company’s offices in Blacksburg, Va., on May 30, 2024. (AP Photo/Shelby Lum)
But where does organ transplantation come in? There aren’t enough donated human organs to go around so researchers are trying to use organs from pigs instead — and that same alpha-gal sugar is a big barrier. It causes the human immune system to immediately destroy a transplanted organ from an ordinary pig. So the first gene that Revivicor inactivated as it began genetically modifying pigs for animal-to-human transplants was the one that produces alpha-gal.
While xenotransplants still are experimental, Revivicor’s “GalSafe” pigs won Food and Drug Administration approval in 2020 to be used as a source of food, and a potential source for human therapeutics. The FDA determined there was no detectable level of alpha-gal across multiple generations of the pigs.
Revivicor, a subsidiary of United Therapeutics, isn’t a food company — it researches xenotransplantation. Nor has it yet found anyone in the agriculture business interested in selling GalSafe pork.
Still, “this is a research pig that FDA approved so let’s get it to the patients,” is how Ayares describes beginning the shipments a few years ago.
Revivicor’s GalSafe herd is housed in Iowa and to keep its numbers in check, some meat is periodically processed in a slaughterhouse certified by the U.S. Agriculture Department. Revivicor then mails frozen shipments to alpha-gal syndrome patients who’ve filled out applications for the pork.
Thank-you letters relating the joy of eating bacon again line a bulletin board near the freezer in Revivicor’s corporate office.
Deeper reading
- Learn how one family’s choice to donate a body for pig kidney research could help change transplants.
- Research on pig-to-human organ transplants, or xenotransplantation, has yielded a surprising benefit for people with red meat allergies caused by the bite of a lone star tick.
- Read more about the latest in organ transplant research.
Separately, pigs with various gene modifications for xenotransplant research live on a Revivicor farm in Virginia, including a GalSafe pig that was the source for a recent experimental kidney transplant at NYU Langone Health.
And that begs the question: After removing transplantable organs, could the pig be used for meat?
No. The strong anesthesia used so the animals feel no pain during organ removal means they don’t meet USDA rules for drug-free food, said United Therapeutics spokesman Dewey Steadman.
—-
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
veryGood! (37626)
Related
- Federal hiring is about to get the Trump treatment
- What is Boxing Day? Learn more about the centuries-old tradition
- The Baltimore Ravens thrive on disrespect. It's their rocket fuel. This is why it works.
- Pregnant 18-year-old who never showed for doctor's appointment now considered missing
- Residents worried after ceiling cracks appear following reroofing works at Jalan Tenaga HDB blocks
- Florida State quarterback Tate Rodemaker won't play in Orange Bowl, but don't blame him
- Pregnant 18-year-old who never showed for doctor's appointment now considered missing
- Search resumes for woman who went into frozen Alaska river to save her dog
- Head of the Federal Aviation Administration to resign, allowing Trump to pick his successor
- Buffalo Bills playoff clinching scenarios for NFL Week 17: It's simple. Win and get in.
Ranking
- Rams vs. 49ers highlights: LA wins rainy defensive struggle in key divisional game
- Authorities in Arizona identify victim of 1976 homicide, ask for help finding family, info
- How Suni Lee Refused to Let Really Scary Kidney Illness Stop Her From Returning For the 2024 Olympics
- Nikki Haley has bet her 2024 bid on South Carolina. But much of her home state leans toward Trump
- Jorge Ramos reveals his final day with 'Noticiero Univision': 'It's been quite a ride'
- Lamar Jackson fires back at broadcaster's hot take about the Ravens
- Spirit Airlines Accidentally Recreates Home Alone 2 After 6-Year-Old Boards Wrong Fight
- Actor Lee Sun-kyun of Oscar-winning film 'Parasite' is found dead in Seoul
Recommendation
Dick Vitale announces he is cancer free: 'Santa Claus came early'
Colombia’s ELN rebels say they will only stop kidnappings for ransom if government funds cease-fire
Turkey hits 70 sites linked to Kurdish groups in Syria and Iraq in retaliation for soldiers’ deaths
Taylor Swift's Game Day Nods to Travis Kelce Will Never Go Out of Style
See you latte: Starbucks plans to cut 30% of its menu
Taylor Swift, 'Barbie' and Beyoncé: The pop culture moments that best defined 2023
Biden orders strikes on an Iranian-aligned group after 3 US troops wounded in drone attack in Iraq
Jason Sudeikis and Olivia Wilde's Kids Steal the Show While Crashing His ESPN Interview